Pet Lab Mouse - CC BY-SA 4.0
Many terminal cancer patients have survived and even been cured by adding repurposed drugs. Repurposed drugs are those deemed safe and effective by the FDA for treating other conditions, like worms or parasites – drugs like Mebendazole or Ivermectin.
Leading cancer researchers at prestigious institutions are now beginning to find that such repurposed drugs can help prevent cancer spread – known as metastasis – which is the ultimate cause of death in most cancer patients. For example, consider this quote from Dr. Gregory Riggins of the Johns Hopkins University School of Medicine.
“We are building on our recent findings that already approved and a relatively non-toxic drug can slow early pancreatic cancer growth and prevent metastasis. Coupled with early detection- this inexpensive drug could save lives. Currently trying to identify a postdoc to spearhead this work.”
Riggins was referring to Mebendazole in his Linkedin post.
Dr. Riggins is the researcher whose test mice with implanted brain cancer developed pinworms. He treated them with Fenbendazole, which killed the worms but curiously also killed their cancers. Thus began his research into the related human drug, Mebendazole, which has shown a massive effect against human cancers, especially against Glioblastoma, the kind my friend Evan has.
Evan has been on a repurposed drug cocktail, including Mebendazole since his brain cancer was found some four years ago.
Despite being given only an average of one year to live, he remains alive and well today. Only about 1% of GBM patients survive their cancers more than two years, and Evan now enjoys being called a long-term survivor.
But as the mainstream media like Yahoo would lead you to believe, is this just a coincidence, or is there a real benefit of taking drugs like Ivermectin and Mebendazole as adjunctive treatment with cancer?
The mainstream media and Big Pharma would prefer you limit your treatment options to expensive and patented new drugs. In contrast, the studies and reports on repurposed drugs suggest they be added for maximum survival.
The published studies in PubMed, the National Library of Medicine, strongly support these repurposed drugs' effect on known cancer signaling and genetic pathways. Beyond that is clinical evidence of benefit. Finally, these drugs are infinitely safer and better tolerated than most toxic chemotherapy agents, which can produce bone marrow suppression, cardiac toxicity, and fatal illness by themselves, never mind cancer.
Consider this clinical trial, METRIC, which used a cocktail of four repurposed drugs, including Mebendazole, to treat GBM. Those patients who received the standard surgery, radiation, and chemotherapy treatment lived an average of 12.7 months, while those on the METRIC cocktail survived an average of 27.1 months, more than double.
Beyond that are case reports of long-term remission.
Few are more famous than the case of Joe Tippens. Joe’s life was going well at the time, immediately before his terrible diagnosis. Tippens was all set to accept a lucrative partnership position in Switzerland when a physician discovered a considerable growth in his left lung [02:10].
“So I picked up the phone and called Switzerland, canceled my trip, canceled my acceptance of that job, and started my journey with MD Anderson (Cancer Center) in Houston, Texas. Through a comedy of errors that weren’t their fault – I got pneumonia along the way, and they had to change the regimen and double up the radiation – they fried my esophagus into bacon when nothing would go down. And instead of doing a feeding tube, I decided to live off my fat and muscle stores, and I went eight weeks with no nutrients in my body – zero [03:03].”
Three months following his diagnosis of Small Cell Carcinoma of the Lung, it had metastasized or spread throughout his body – “from head to toe.”
“I had tumors in my neck, stomach, bladder, pancreas, and bones from head to toe [03:55]. I don’t know if your listeners know, but when you have small cell cancer that has metastasized that far afield, you’re basically a goner – the life expectancy goes below 1%. The median life expectancy is around three months [04:18].”
Joe Tippens was told to hire hospice and get his affairs in order – essentially to get ready to die.
After he told his friends and family the dire news, an old college friend – a large animal veterinarian told him about the mice and suggested he might take Fenbendazole, the veterinary version of Mebendazole. In addition, Tippens did his research and wisely added bioavailable Curcumin. As it turns out, much data mechanistically supports the anti-cancer action of Curcumin.
As Dr. Paul Marik has found, “Curcumin has an impact on the tumor microenvironment by inhibiting angiogenesis even under the hypoxic status within the tumor microenvironment. [1] Furthermore, curcumin has activity against cancer stem cells in addition to promoting apoptosis. [1,3,4] Curcumin induces apoptosis in tumor cells,[2] through ROS-mediated endoplasmic reticulum (ER) stress and mitochondrion-dependent pathways.[1] In addition, curcumin acts through the Wnt/-catenin pathway. [5]”
He threw in CBD oil and Vitamin E for good measure. Then he waited. As Tippens explains it, “I went through a period of unknown. I went all the way through January, February, March and April of 2017 waiting to die because the median life expectancy was three months,
Keep reading with a 7-day free trial
Subscribe to Repurposed Drugs: Powers & Possibilities to keep reading this post and get 7 days of free access to the full post archives.